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Steroid 5a-reductase is of crucial importance in androgen
physiology because it catalyzes the conversion of testo-
sterone into the more potent 5a-dihydrotestosterone in
androgen-regulated target tissues. The enzyme occurs in
two isoforms, whereby type 1 isozyme exists mainly in
the skin and type 2 in the prostate. By using human
cell cultures, we examined cutaneous expression and
subcellular localization of type 1 5a-reductase in vitro. In
immunocytochemistry, type 1 5a-reductase was detected
in the cytoplasm of cultured human sebocytes, ker-
atinocytes, fibroblasts, dermal microvascular endothelial
cells, hair dermal papilla cells, and melanocytes. In
western blot studies, two closely lying bands of 21–27 kDa
were detected, possibly indicating heterogeneity of the
Steroid 5α-reductase is the enzyme that catalyzes the conver-sion of testosterone (T) to 5α-dihydrotestosterone (DHT).The conversion of T to DHT amplifies the androgenicsignal through two mechanisms: (i) DHT, unlike T, cannotbe aromatized to estrogen, and thus its effect remains purely
androgenic; and (ii) in vitro DHT binds to the human androgen receptor
with greater affinity than does T, and the DHT-receptor complex
appears to be more stable (Anderson and Liao, 1968; Ito and Horton,
1971; Kovacs et al, 1984).
Studies in the 1970s and 1980s have revealed that the skin, in
addition to the prostate, is rich in 5α-reductase (Hay and Hodgins,
1973; Sharp et al, 1976; Takayasu et al, 1980). In this respect, it appears
very likely that 5α-reductase functions as an autocrine mediator in
skin growth and differentiation. Comparison of the expression and
distribution of 5α-reductase in normal versus diseased skin could also
help to further elucidate the etiopathogenesis of androgen-dependent
skin disorders, such as acne vulgaris, hirsutism, androgenetic alopecia,
and seborrhea.
In the last decade, molecular cloning studies have characterized two
genes that encode two isozymes of 5α-reductase, namely, type 1 and
type 2 (Andersson and Russell, 1990; Andersson et al, 1991). The
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type 1 5a-reductase in all the cell types tested, with the
exception of beard dermal papilla cells. Northern blot
studies revealed most abundant type 1 mRNA in neonatal
foreskin keratinocytes, followed by adult facial sebocytes.
Occipital hair dermal papilla cells presented higher levels
of type 1 5a-reductase mRNA than those of beard. These
findings were confirmed by semiquantitative reverse tran-
scriptase polymerase chain reaction coupled with high
performance liquid chromatography analysis. Taken
together, it seems likely that in cultured human skin cells
there exist (i) heterogeneity of type 1 5a-reductase protein
and (ii) quantitative differences in its transcriptional and
translational expression levels. Key word: skin cell cultures.
J Invest Dermatol 110:84–89, 1998
former exists predominantly in the skin, whereas the latter exists in
the prostate (Jenkins et al, 1992). The cutaneous distribution of type 1
isozyme in vivo was identified immunohistochemically to be in the
sebaceous glands, epidermis, eccrine sweat glands, apocrine sweat
glands, and hair follicles (outer root sheath cells, dermal papilla cells,
matrix cells) as well as in the endothelial cells of small vessels and the
Schwann cells of cutaneous myelinated nerves (Luu-The et al, 1994;
Eicheler et al, 1995). The subcellular localization, however, is still
controversially described. The type 1 isozyme was found by some
authors to be localized in the nuclei of skin cells (Itami et al, 1990;
Eicheler et al, 1995) and by others to be localized in the cytoplasm
(Luu-The et al, 1994; Patel et al, 1996). Moreover, the relative amounts
of the enzyme in different cells or in the same cell type from different
skin areas remain to be determined.
In the present study, by using human cell cultures we have
demonstrated immunocytochemically the presence of type 1 5α-
reductase in the cytoplasm of all the skin cell types tested, including
melanocytes. Evidence of heterogeneity of the enzyme protein was
observed in western blotting study. Quantitative differences in the
isozyme expression among the cells were shown at the transcriptional
as well as at the translational levels.
MATERIALS AND METHODS
Cell cultures Unless otherwise stated, all the cells were cultuted in 100 mm
Petri dishes (Falcon 3003 Becton Dickinson, Plymouth, U.K.) at 37°C in a
humidified atmosphere containing 5% CO2. The medium was replaced every
3 d.
Sebocyte culture Primary sebocyte cultures were obtained as previously
described (Xia et al, 1989). Skin specimens from the facial area of middle-to
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old-aged patients (50–70 y old) undergoing surgical excision were cut in small
fragments and incubated for 20 h in 3 U dispase (Boehringer, Mannheim,
Germany) per ml at 4°C to separate epidermis from dermis. Epidermis was
then maintained for 15 min in 0.02% desoxyribonuclease (Sigma, Deisenhofen,
Germany) at 37°C. Intact sebaceous glands were microdissected and the isolated
lobules were cultivated on mitomycin C (Sigma)-inactivated 3T3 cells in
sebocyte medium consisted of Dulbecco’s modified Eagle’s medium/Ham’s F
12 medium (3:1, Biochrom, Berlin, Germany), 10% fetal calf serum (Seromed,
Berlin, Germany), 10 ng epidermal growth factor (Sigma) per ml, 10 ng
keratinocyte growth factor (Boehringer) per ml, 10–9 M cholera toxin (Sigma),
3.4 mM L-glutamine (Seromed), 100 IU penicillin (Seromed) per ml, and
100 µg streptomycin (Seromed) per ml. Outgrowths from the periphery of the
gland lobules were usually first seen in 5–7 d. The cells of the first two passages
were used in this study.
Culture of human dermal papilla cells Individual hair follicles were
isolated by microdissection from skin specimens of human occipital scalp and
beard area. This was achieved by using a scalpel blade to cut through the skin
at the dermo-subcutaneous fat interface. The intact hair follicles were then
removed from the subcutaneous fat by gently gripping the outer root sheath of
the follicle with microforceps and pulling the hair follicle from the subcutaneous
fat. The proximal one-third of hair follicles containing the hair bulbs were
dissected in Dulbecco’s modified Eagle’s medium (Biochrom) supplemented
with 10% fetal calf serum, 100 IU penicillin per ml, 100 µg streptomycin
per ml, 2 mM L-glutamine, and 50 ng amphotericin B (Sigma) per ml. The
follicular fragments were then treated with 30 U dispase solution per ml for
15 min at 37°C (Chiu et al, 1993) and transferred to a Petri dish containing the
same medium with 20% fetal calf serum. Each follicle was carefully microdis-
sected, to separate out the dermal papilla, and three to five isolated dermal
papillae were individually transferred to one 35-mm Petri dish (Messenger,
1984). Primary cultures were incubated undisturbed for 5–7 d, then the medium
was changed every 3 d. Subcultures were performed after 4–5 wk, when
sufficient cells were present. Cells of the third passage were used for the study.
Fibroblast culture Fibroblasts were cultured by explant outgrowth from
small pieces of dermal tissue taken from skin sites in occipital scalp, chin, and
shoulders, in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal calf serum, 100 IU penicillin per ml, 100 µg streptomycin per ml, and
2 mM L-glutamine.
Keratinocyte culture Keratinocytes from neonatal foreskin and adult non-
genital skin regions like flank or arm were cultured in serum-free keratinocyte
medium (Gibco BRL, Berlin, Germany) supplemented with 5 ng epidermal
growth factor per ml and 50 µg bovine pituitary extract (Clonetics, San Diego,
CA) per ml. Cells of the second passage were used for these experiments.
Melanocyte culture Normal human melanocytes were obtained and prepared
as described before (Krasagakis et al, 1991). Primary cultures were maintained
in modified MCDB 153 medium (Seromed) with amino acids and the following
supplements: 2 mM Ca21, 10 µg human transferrin per ml, 5 µg insulin (Sigma)
per ml, 0.4% vol/vol whole bovine pituitary extract, 2 ng bovine basic fibroblast
growth factor (Boehringer) per ml, 10–9 M cholera toxin, 50 µM hydrocortisone
(Sigma), 100 IU penicillin per ml, and 100 µg streptomycin per ml. Ten per
cent fetal calf serum was added within the first 2 d of the primary culture and
the first 24 h of each subculture. After µ3 wk in culture any keratinocytes had
degenerated and detached leaving an essentially pure growth of melanocytes
with no detectable contamination by other cell types.
Culture of dermal microvascular endothelial cells A cell line of dermal
microvascular endothelial cells was used (generous offer by Dr. E.W. Ades,
Atlanta, Emory University, GA; Ades et al, 1992). The cells were cultured in
endothelial basal medium supplemented with 2% fetal calf serum, 10 ng
epidermal growth factor per ml, 1 µg hydrocortisone per ml, 50 µg gentamicin
per ml, 50 ng amphotericin B per ml, and 3.0 mg bovine brain extract per ml
(all Clonetics).
Immunocytochemistry The cultured cells were cytocentrifuged (Cytospin
2, Shandon, Frankfurt, Germany) on microscopic slides at a density of 25,000
cells per 200 µl and fixed with cold acetone for 15 min. The primary and
secondary antibodies used were rabbit serum anti-human type 1 5α-reductase
antibody (Luu-The et al, 1994) and alkaline phosphatase anti-alkaline phosphat-
ase complex-conjugated goat-anti-rabbit IgG (H 1 L) monoclonal antibody
(Dianova, Hamburg, Germany), respectively, both at dilutions of 1:100 in
solutions containing 10% RPMI 1640 (Biochrom) and 10% fetal calf serum,
pH 7.4.
RNA and protein isolation Total RNA and proteins were simultaneously
isolated in a single-step reaction using a mono-phase solution of phenol,
guanidine thiocyanate, buffer, and solubilizing agents (TRIzol, Gibco BRL/
Life Technologies, Gaithersburg, MD) (Chomczynski, 1993). Cells in monolayer
culture were first washed with phosphate-buffered saline twice and directly
lysed in culture dishes by the addition of the reagent. In order to rule out the
contamination of genomic DNA, the RNA yield was treated with RNAse-
free DNAse (Boehringer Ingelheim, Heidelberg, Germany) for 10 min at 37°C.
The amount of RNA was spectrophotometrically determined with OD260/
OD280 ratio above 1.8. By use of bicinchoninic acid (Pierce BCA protein assay
reagent, Rockford, IL), the protein concentration was quantitated by measuring
the absorbance at 550 nm with an enzyme-linked immunosorbent assay reader
(Dynatech MR5000, Denkendorf, Germany).
Western blot analysis Aliquots (5–10 µg) of total protein isolated from the
cultured cells were heated for 15 min at 95°C to denaturize proteases (Johnstone
and Thorpe, 1987). Sodium dodecyl sulfate/polyacrylamide gel electrophoresis
of each sample was performed on a 12.5% gel. Proteins were transferred to a
immobilon-P PVDF transfer membrane (Millipore, Eschborn, Germany), using
a semi-dry blotting system (Bio-Rad, Munich, Germany). The blots were
probed with a 1:1000 dilution of rabbit anti-serum raised against human type
1 5α-reductase and then with alkaline phosphatase anti-alkaline phosphatase
complex-conjugated goat anti-rabbit antibody in a final concentration of 0.5 µg
per ml (Oncogene Science, Cambridge, MA). After thorough washing, the
signal was visualized using a combination of nitro-blue tetrazolium and 5-
bromo-4-chloro-3-indolyl phosphate as substrates for the phosphatase reaction
(Zymed, San Francisco, CA).
Northern blot analysis Ten µg total RNA isolated from the cultured cells
was denaturized and size-fractionated by electrophoresis over 1.2% agarose
gel containing 3-(N-morpholino)propanesulfonic acid/formaldehyde and then
transferred to a supported, positively charged nylon membrane (GeneScreen
Plus, Dupont, Boston, MA). After baking for 2 h at 80°C, the blots were
sequentially hybridized against 32P-labeled probes for human type 1 5α-
reductase, β-actin, and glyceraldehyde 3-phosphate dehydrogenase (G3PDH),
respectively, which were prepared by recovery of polymerase chain reaction
(PCR) products from amplification of corresponding primers. Exposure to
autoradiography film (Kodak X-OMAT, Sigma, Germany) was done at –70°C
(Sambrook et al, 1989). The results were analyzed by densitometry (Bio Profil,
Vilber Lourmat, Marne La Valle`e, France).
Semiquantitative reverse transcriptase PCR coupled with high perform-
ance liquid chromatography (HPLC) analysis The kinetic method was
utilized in this experiment. In order to avoid tube-to-tube variations, the primer
pair for a 368-bp type 1 5α-reductase fragment (forward 59-TGG CGC TTC
TCT ATG GAC TT-39, reverse 59-GGA AGC AAC ACT GCA GTT GA-
39) (sequences kindly provided by Drs. Eicheler and Hoffmann, Marburg,
Germany) and a second primer pair of a 227-bp housekeeping gene β-actin
fragment (forward 59-GGG AAA TCG TGC GTG ACA TT-39, reverse 59-
GGA GTT GAA GGT AGT TTC GTG-39), as endogenous internal standard,
were mixed together from the beginning in the same tube during PCR
amplification (Noonan et al, 1990; Van Hille et al, 1995). In the preceding step,
we decided the relative concentrations of each primer pair and the appropriate
range of PCR cycles. The aim was to establish a linear logarithmic relationship
between the PCR amplicons and the cycle numbers. PCR amplification of the
complementary DNA (cDNA) was carried out using the ‘‘hot start’’ technique
for 14–28 consecutive cycles in 50 µl of amplification buffer (Perkin-Elmer,
Weiterstadt, Germany) containing 1.25 U per reaction Tag DNA polymerase
(Perkin-Elmer), and 59 and 39 primers in concentration of 0.5 µM and 0.125 µM
for type 1 5α-reductase and β-actin, respectively. The thermal profile was
initially 94°C for 5 min, followed by the indicated number of cycles at 94°C
for 45 s, at 60°C for 45 s, at 72°C for 90 s, and finally at 72°C for 10 min in
a programmable thermal controller (PTC-100, MJ Research, Watertown, MA).
The total amount of end products in 50 µl were directly loaded on the HPLC
system (LKB Bromma, Pharmacia Biotech, Freiburg, Germany) set up with a
diethylaminoethyl anion guard column (5.0 mm long 3 4.6 mm internal
diameter; Perkin-Elmer) and diethylaminoethyl anion exchange column (3.5 cm
long 3 4.6 mm internal diameter, Perkin-Elmer). The mobile phase consisted
of various volume proportions of buffer A (25 mM/Tris-HCl, pH 9.0, plus
1 M NaCl) and buffer B (25 mM/Tris-HCl, pH 9.0) in the following gradient
program (A/B): 0 min, 30/70; 0.5 min, 50/50; 4.0 min, 56/44; 14.0 min, 61/
39; 14.5 min, 100/0; 19.5 min, 100/0; 20.0 min, 30/70; 25.0 min, 30/70. The
total flow rate was 1 ml per min. φ X174 RF DNA/Hae III fragments (Gibco
BRL) were used as external DNA standards. The signal was detected with
260 nm ultraviolet light. Utilizing a computer program, we assessed the original
amount of the mRNA of interest and that of standard β-actin. The ratio in
between was used to assess the quantitative differences between different cell
types under examination.
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Figure 1. Results of immunocytochemistry using rabbit anti-serum raised against human type 1 5a-reductase. (a) Adult facial sebocytes; (b) neonatal
foreskin keratinocytes; (c) adult nongenital keratinocytes (flank); (d) occipital dermal papilla cells; (e) beard dermal papilla cells; (f) occipital fibroblasts; (g) melanocytes;
(h) dermal microvascular endothelial cells; (i) chin fibroblasts. Scale bars, 50 µm.
RESULTS
Immunocytochemistry The staining procedure was first established
on skin tissue with sebaceous glands, which are known to express type
1 5α-reductase. The enzyme protein was located in the cytoplasm,
not in the nucleus, of all the cell types tested (Fig 1). The intensity of
the expression could be broadly divided into three groups, in order of
decreasing intensity: (i) adult facial sebocytes and neonatal foreskin
keratinocytes, (ii) occipital dermal papilla cells, occipital fibroblasts,
shoulder fibroblasts, keratinocytes from nongenital area (flank), and
(iii) beard dermal papilla cells, chin fibroblasts, melanocytes, dermal
microvascular endothelial cells. Moreover, among sebocytes, the smaller,
undifferentiated sebocytes were more strongly stained than the larger,
differentiated ones (Fig 2).
Western blotting The molecular weight of type 1 5α-reductase
protein is between 28 and 29 kDa (Andersson and Russell, 1990);
however, in sodium dodecyl sulfate/polyacrylamide gel electrophoresis,
the isozymes show aberrant electrophoretic mobility because of high
hydrophobic amino acid contents, and migrate with molecular weights
of 21–27 kDa (Russell and Wilson, 1994). When 5 µg per protein
sample was loaded, only sebocytes and neonatal foreskin keratinocytes
showed positive results. When 10 µg per protein samples were exam-
ined and concentration of the sodium dodecyl sulfate gel was elevated
above 10%, two corresponding bands lying closely together were
demonstrated in all the cultured cells under examination, with the
exception of beard dermal papilla cells (Fig 3). The expressional
intensity of type 1 5α-reductase was stronger in neonatal foreskin
keratinocytes than in keratinocytes from adult nongenital areas, and it
was also stronger in occipital dermal papilla cells than in beard dermal
papilla cells.
Figure 2. Immunocytochemistry of adult facial sebocytes from the
fourth passage in culture. The smaller, less differentiated sebocytes are more
strongly stained with anti-type 1 5α-reductase antibody as compared with
larger, well-differentiated ones. Scale bar, 50 µm.
Northern blotting The sizes of the type 1 5α-reductase, β-actin,
and G3PDH mRNA were estimated to be 2.4 kb, 1.7 kb, and 1.3 kb,
respectively, which are compatible with those described in the literature
(Nakajima-Iijima et al, 1985; Allen et al, 1987; Andersson and Russell,
1990). Densitometrical analysis revealed that the expression of type 1
5α-reductase mRNA, corrected by the amount of G3PDH, was (i)
most abundant in neonatal foreskin keratinocytes, followed by adult
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Figure 3. Results of western blot study with 12.5% sodium dodecyl
sulfate/polyacrylamide gel electrophoresis. With the exception of beard
dermal papilla cells, all the cells under examination show two closely lying
bands in the range of molecular weight 21–27 kDa.
Figure 4. Results of northern blot study with 1.2% MOPS/fomaldehyde
agarose gel. Quantitative differences are observed among different cell types,
after correction by β-actin and G3PDH, respectively, which show a parallel
relationship.
Table I. Densitometrical data of northern blot analysis (the
5a-reductase/G3PDH ratio in sebocytes was assessed J 1)
5α-reductase/G3PDH ratio
Sebocyte 1
Keratinocyte (foreskin) 3.83
Keratinocyte (flank) 0.66
Dermal papilla (occipitus) 0.41
Dermal papilla (beard) 0.08
Fibroblast (occipitus) 0.70
Fibroblast (chin) 0.19
Fibroblast (shoulder) 0.44
Melanocyte 0.31
Endothelium 0.24
facial sebocytes, (ii) stronger in occipital dermal papilla cells as compared
with that in beard, and (iii) different in fibroblasts from different skin
areas (Fig 4 and Table I).
Semiquantitative reverse transcriptase PCR The initial amounts
of target mRNA (type 1 5α-reductase and β-actin) were obtained by
using linear regression of the logarithmic area under concentration
values of the serially individual HPLC peak (Fig 5). The ratios
inbetween, i.e., type 1 5α-reductase/β-actin, from three experiments
ranged from 1.5- to 10-fold higher in neonatal foreskin keratinocytes
as compared with that in adult facial sebocytes (Fig 6), which verified
the results of our northern blot study.
DISCUSSION
The expression and distribution of 5α-reductase isozymes in human
skin have been investigated mainly in vivo by means of (i) performing
enzyme assay in isolated tissues or cultured cells (Voigt et al, 1970;
Figure 5. (a) DNA standards; (b) b-actin and type 1 5a-reluctase PCR
products. (a) HPLC analysis of PCR products from 22 cycles amplification.
cDNA of β-actin and type 1 5α-reductase were amplified in the same tube,
whereby the concentration of β-actin primers was one-fourth of that of type 1
5α-reductase primers (0.125 µM vs 0.5 µM). (b) Elution of PCR products was
correlated to size in accordance with HPLC analysis of DNA standards.
Figure 6. Linear correlations between PCR cycles and area under
concentration of HPLC analysis. The appropriate cycles for type 1 5α-
reductase and β-actin were shown to be 22–28 and 14–20, respectively. The
value of type 1 5α-reductase in neonatal foreskin keratinocytes, when corrected
with β-actin, is about 1.5–10 higher that of adult facial sebocytes.
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Takayasu and Adachi, 1972; Hay and Hodgins, 1973; Sharp et al, 1976;
Takayasu et al, 1980) or (ii) detecting the enzyme localization on skin
specimens by specific antibodies (Luu-The et al, 1994; Eicheler et al,
1995). To verify and compare the in vivo results, we have used skin
cell cultures in vitro for cytochemical and molecular biologic studies.
Because the antibodies described in the literature were raised against
different peptide sequences in different animals, the results regarding
the cutaneous distribution of the 5α-reductase isozymes vary among
different research groups (Thigpen et al, 1993; Luu-The et al, 1994;
Eicheler et al, 1995; Patel et al, 1996). There is agreement on the
expression of type 1 isozyme in sebaceous glands, keratinocytes, and
eccrine sweat glands. In contrast, the isozyme expression in different
parts of hair follicles remains controversial and no data are available
about its expression in melanocytes and Langerhans cells. Additional
questions include the subcellular localization of the enzyme and whether
there exist quantitative differences in the same cell type from different
skin regions as well as differences between healthy persons and
diseased subjects.
Our findings clarify the following issues: (i) the presence of type 1
5α-reductase in the cytoplasm of all cultured skin cell types under
examination; (ii) the possibility of the existence of heterogeneous
human type 1 5α-reductase proteins; (iii) the strongest expression of
type 1 5α-reductase in facial sebocytes among skin cells from adult
subjects; (iv) the stronger expression of type 1 5α-reductase in neonatal
foreskin keratinocytes than in adult facial sebocytes; (v) the regional
variance of type 1 5α-reductase expression in fibroblasts and ker-
atinocytes; (vi) the presence of type 1 5α-reductase in dermal papilla
cells of both beard and occipital scalp, and the stronger expression in
the latter; and (vii) the expression of type 1 5α-reductase in cultured
melanocytes.1
To explain the two closely lying bands on western blotting, the
following possibilities should be considered: (i) the presence of hetero-
geneity of human type 1 isozyme protein; (ii) the enzyme existence
in two states, activated or inactivated, through phosphorylation or
dephosphorylation; and (iii) a partial protein denaturation during the
process of extraction/isolation. The first observation is supported by a
recent study that revealed the presence of two forms of mRNA species
for rat type 1 5α-reductase (Lopez-Solache et al, 1996). The newly
isolated cDNA clones encoded a longer protein with four additional
amino acids in the NH2-terminal region, and the protein had a higher
substrate affinity than the previously reported one. The presence of
heterogeneous type 1 protein isozymes in all the cells tested except
beard dermal papilla cells, could be of the following significance: (i) it
may help to explain the discrepancy of the available findings with
regard to enzyme distribution and subcellular localization; (ii) it may
elucidate the different responses of hair follicles from different skin
areas (beard, occipital, and frontal scalp) to androgens; and (iii) it
should be taken into account in perspective of treatment of androgenetic
alopecia. It is unlikely that the type 1 5α-reductase anti-serum used
cross-reacted with type 2 5α-reductase, because sebocytes that expressed
two bands in western blotting were found not to express type 2 5α-
reductase at the mRNA level (data not shown).
The strongest expression of type 1 5α-reductase in sebocytes among
the adult skin cells examined confirms our previous hypothesis that
the sebaceous gland would be the main source of high concentration
of tissue-active androgens in the pilosebaceous unit (Zouboulis et al,
1994; Zouboulis et al, in press). When we consider that the sebocytes
examined in this study originated from older subjects, who have been
shown to exhibit a lower sebocyte activity as compared with younger
individuals (Pochi and Strauss, 1974), we may expect even higher 5α-
reductase expression in sebocytes deriving from young subjects.
The abundance of type 1 5α-reductase in neonatal foreskin
keratinocytes highlights the importance of DHT in the growth and
differentiation of epidermis. In this respect, the DHT secreted by
keratinocytes may be of autocrine as well as paracrine function for the
1Since this paper was written another work (Tadokoro et al, 1997) has been
published confirming 5α-reductase type 1 expression in human melanocytes
from genital skin.
development of skin and skin appendages in the period of time from
shortly after birth until puberty, whereas the sebaceous glands cease to
work. It is worth examining further (i) whether the expression of type
1 5α-reductase in keratinocytes decreases with aging, and (ii) the
role of androgens in the physiologic function of epidermis, such as
maintenance of the integrity of skin barrier.
By studying patients with familial incomplete male pseudohermaph-
roditism type 2 (now termed type 2 5α-reductase deficiency syndrome),
it was demonstrated that fibroblasts from nongenital areas possess type
1 isozyme, whereas those from the genital area display type 2 isozyme
(Moore et al, 1975; Moore and Wilson, 1976). Our results further
point out the existence of quantitative differences in the expression of
type 1 5α-reductase in fibroblasts among nongenital skin areas (chin,
scalp, shoulder).
The expression pattern of the type 1 versus type 2 isozymes in human
hair dermal papilla cells has been the subject of vigorous discussion.
The results of early studies in the 1970s, which were obtained by
incubating the plucked human hair follicles with radiolabeled T and
other androgen precursors, do not provide valuable information,
because the plucked human hairs usually leave the dermal papilla in
the skin (Fazekas and Lanthier, 1971; Takayasu and Adachi, 1972;
Schweikert and Wilson, 1974). Itami et al (1990) showed that the 5α-
reductase of beard dermal papilla cells exhibited an pH optimum at
5.5, which corresponds to type 2 isozyme, whereas the enzyme of
occipital dermal papilla cells showed a broad and low plateau between
pH 6.0 and 9.0, which is optimal for type 1 isozyme. Thornton et al
(1993) showed that significant amounts of DHT were recovered inside
beard dermal papilla cells, but not in occipital dermal papilla cells.
There were no significant differences in the substrate specificity
between these two types of cells. Harris et al (1992) showed that the
5α-reductase in human scalp obtained during hair transplantation (site
not clearly defined, possibly fronto-parietal area) has a broad pH
optimum centered at pH 7.0 (corresponding to type 1 isozyme). Two
4-azasteroids and a 3-carboxyandrostadione were shown to be potent
inhibitors of the prostate reductase but weak on the scalp reductase.
Immunohistochemical studies, however, showed controversial results;
the type 1 isozyme was demonstrated by Eicheler et al (1995) in the
dermal papilla cells from the scalp (skin region unknown), whereas it
was detected by Patel et al (1996) only in the sebaceous glands in
balding scalp. In the present study, we have demonstrated the presence
of type 1 5α-reductase in both cultured occipital and beard dermal
papilla cells, whereby a stronger expression was observed in the former.
There was no heterogeneity of type 1 5α-reductase in beard dermal
papilla cells under examination.
The expression of 5α-reductase in melanocytes is an additional
interesting finding, the significance of which is unknown. Because the
maturation or transformation of vellous hair to terminal hair involves
the melanin production by melanocytes situated in the hair dermal
papilla (Randall, 1994) and the outgrowth of pigmented terminal hairs
in hirsutism, it could be supposed that the presence of 5α-reductase
in melanocytes and the local production of DHT may play a role in
the melanin production. The effect of DHT on the tyrosinase activity
remains to be determined. On the other hand, it is well documented
that women with melanoma present a better prognosis compared with
male subjects (Shaw et al, 1980; Karjalainen and Hakulinen, 1988). An
in vitro study recently showed that addition of flutamide, an anti-
androgen agent, to cultured IIB-MEL-J melanoma cells in the presence
of serum significantly inhibited cell proliferation in a dose-dependent
manner (Morvillo et al, 1995). When cells were incubated with 10 nM
DHT and 1% charcoal-adsorbed serum, a significant stimulation of
growth was observed and this was inhibited by 4 µM OH-flutamide.
This observation, together with our finding, raises the question of the
roles of androgens and 5α-reductase in the biology of melanoma cells.
In summary, by using skin cell cultures in vitro, we have demonstrated
the cytoplasmic localization of type 1 5α-reductase. We have also
detected possible heterogeneity and quantitative differences of type 1
5α-reductase in skin cells, including melanocytes. This finding may
help to explain some of the discrepancies of previous results. Further
examination and comparison of the type as well as the amount of 5α-
reductase isozymes between normal and diseased subjects in various
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stadium (acne vulgaris, androgenetic alopecia, hirsutism) could help us
better understand the etiopathogenesis of these androgen-dependent
skin disorders.
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